🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Navidea Biopharmaceuticals, Inc. (NAVBQ)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Nov 18, 2026

NAVBQ Revenue

Navidea Biopharmaceuticals had revenue of $610.00 in the twelve months ending September 30, 2023, down -99.47% year-over-year. In the year 2022, Navidea Biopharmaceuticals had annual revenue of $65.65K, down -87.65%. That makes Navidea Biopharmaceuticals the 47,706th largest company in the world by revenue and 7,304th in the United States.

Revenue (ttm)
610.00
Revenue Growth
-99.47%
P/S Ratio
0.16
Revenue / Employee
46.92
Employees
13
Market Cap
100.00

Revenue Chart

Revenue by Geography

  • Europe 14.04K 95.8%
  • Australia 610.00 4.2%
Fiscal year ended Dec 31, 2022

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202265.65K-465.86K-87.65%
Dec 31, 2021531.51K-383.50K-41.91%
Dec 31, 2020915.01K257.19K39.10%
Dec 31, 2019657.83K-511.53K-43.74%
Dec 31, 20181.17M-641.09K-35.41%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2013 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
ObsEva19.64M
Gelesis Holdings12.14M
Infinity Pharmaceuticals2.57M
Cardax500.71K
0913693 B.C.249.09K
Marizyme183.42K
Revenue Rankings